Rapid identification of smith-lemlip-opitz syndrome homozygotes and heterozygotes (carriers) by measurement of deficient 7-dehydrocholesterol-Δ7-reductase activity in fibroblasts
- 31 July 1997
- journal article
- Published by Elsevier in Metabolism
- Vol. 46 (7) , 844-850
- https://doi.org/10.1016/s0026-0495(97)90133-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes.Journal of Clinical Investigation, 1995
- Detection of defective 3β‐hydroxysterol Δ7‐reductase activity in cultured human fibroblasts: a method for the diagnosis of Smith‐Lemli‐Opitz syndromeJournal of Inherited Metabolic Disease, 1995
- Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblastsClinica Chimica Acta; International Journal of Clinical Chemistry, 1995
- Defective Cholesterol Biosynthesis Associated with the Smith-Lemli-Opitz SyndromeNew England Journal of Medicine, 1994
- Different feedback regulation of hepatic cholesterol and bile acid synthesis by glycodeoxycholic acid in rabbitsGastroenterology, 1993
- Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndromeThe Lancet, 1993
- Cholesterol-mediated regulation of HMG-CoA reductase in microsomes from human skin fibroblasts and rat liverBiochemistry and Cell Biology, 1990
- Regulation of the mevalonate pathwayNature, 1990
- [19] Receptor-mediated endocytosis of low-density lipoprotein in cultured cellsPublished by Elsevier ,1983
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955